Article
Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.
Journal of translational medicine - 3 Jan 2022
Wang Renxi
Abstract excerpt
BACKGROUND: Observational studies and previous Mendelian randomization (MR) studies have shown that genetically low 25-hydroxyvitamin D (25OHD) levels are associated with a high susceptibility to multiple sclerosis (MS). The present MR study aims to update the causal estimates for the effects of 25OHD levels on MS risk. METHODS: To date, the largest genome-wide association study (GWAS) for serum 25OHD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
